Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Trace element concentrations in blood plasma from diabetic patients and normal individuals.

Ward MI, Pim B.

Biol Trace Elem Res. 1984 Dec;6(6):469-87. doi: 10.1007/BF02987202.

PMID:
24264305
2.

Oxidation of fatty acids and tricarboxylic acid cycle intermediates by isolated rat liver mitochondria.

KENNEDY EP, LEHNINGER AL.

J Biol Chem. 1949 Jun;179(2):957-72. No abstract available.

PMID:
18150026
3.

Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism.

Watts LM, Manchem VP, Leedom TA, Rivard AL, McKay RA, Bao D, Neroladakis T, Monia BP, Bodenmiller DM, Cao JX, Zhang HY, Cox AL, Jacobs SJ, Michael MD, Sloop KW, Bhanot S.

Diabetes. 2005 Jun;54(6):1846-53.

4.

Low-level arsenite activates the transcription of genes involved in adipose differentiation.

Salazard B, Bellon L, Jean S, Maraninchi M, El-Yazidi C, Orsière T, Margotat A, Botta A, Bergé-Lefranc JL.

Cell Biol Toxicol. 2004 Nov;20(6):375-85.

PMID:
15868481
5.

Mortality among children residing near the American Smelting and Refining Company (ASARCO) copper smelter in Ruston, Washington.

Tollestrup K, Frost FJ, Harter LC, McMillan GP.

Arch Environ Health. 2003 Nov;58(11):683-91.

PMID:
15702892
6.
7.

Prevalence of chronic diseases in adults exposed to arsenic-contaminated drinking water.

Zierold KM, Knobeloch L, Anderson H.

Am J Public Health. 2004 Nov;94(11):1936-7.

9.

Inhibition of insulin-dependent glucose uptake by trivalent arsenicals: possible mechanism of arsenic-induced diabetes.

Walton FS, Harmon AW, Paul DS, Drobná Z, Patel YM, Styblo M.

Toxicol Appl Pharmacol. 2004 Aug 1;198(3):424-33.

PMID:
15276423
10.

Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice.

Waalkes MP, Liu J, Ward JM, Diwan BA.

Toxicol Appl Pharmacol. 2004 Aug 1;198(3):377-84.

PMID:
15276417
11.

Protective effect of N-acetylcysteine against arsenic-induced depletion in vivo of carbohydrate.

Pal S, Chatterjee AK.

Drug Chem Toxicol. 2004 May;27(2):179-89.

PMID:
15198077
12.

Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.

Bazuine M, Carlotti F, Tafrechi RS, Hoeben RC, Maassen JA.

Mol Endocrinol. 2004 Jul;18(7):1697-707. Epub 2004 Apr 15.

PMID:
15184525
13.

The potential biological mechanisms of arsenic-induced diabetes mellitus.

Tseng CH.

Toxicol Appl Pharmacol. 2004 Jun 1;197(2):67-83. Review.

PMID:
15163543
14.

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Wild S, Roglic G, Green A, Sicree R, King H.

Diabetes Care. 2004 May;27(5):1047-53.

PMID:
15111519
15.
16.

Protective effect of methionine supplementation on arsenic-induced alteration of glucose homeostasis.

Pal S, Chatterjee AK.

Food Chem Toxicol. 2004 May;42(5):737-42.

PMID:
15046819
17.

Arsenite stimulated glucose transport in 3T3-L1 adipocytes involves both Glut4 translocation and p38 MAPK activity.

Bazuine M, Ouwens DM, Gomes de Mesquita DS, Maassen JA.

Eur J Biochem. 2003 Oct;270(19):3891-903.

18.

EFFECT OF ANAEROBIOSIS AND CELL POISONS ON GLUCOSE UPTAKE OF HEMIDIAPHRAGMS AND EPIDIDYMAL FAT PADS IN VITRO.

SHORT AL, WRIGHT FE, WHITNEY JE.

Diabetes. 1965 Mar;14:128-31. No abstract available.

PMID:
14262219
19.

Gene expression of inflammatory molecules in circulating lymphocytes from arsenic-exposed human subjects.

Wu MM, Chiou HY, Ho IC, Chen CJ, Lee TC.

Environ Health Perspect. 2003 Aug;111(11):1429-38.

20.

Chronic studies evaluating the carcinogenicity of monomethylarsonic acid in rats and mice.

Arnold LL, Eldan M, van Gemert M, Capen CC, Cohen SM.

Toxicology. 2003 Aug 28;190(3):197-219.

PMID:
12927375

Supplemental Content

Support Center